Results 151 to 160 of about 1,518 (174)

Neuropsychological profile associated to PKAN in its initial phase: a case series report

Neurocase, 2022
Pantothenase kinase-associated neurodegeneration (PKAN) is characterized by an abnormal accumulation of iron in basal ganglia and progressing varied extrapyramidal clinical symptoms. There are few studies on the cognitive symptoms and their development.
Ana Belén Vintimilla Tosi, María Damià-Vidal, Joaquín A. Ibáñez-Alfonso, David Saldaña   +3 more
openaire   +2 more sources

Glymphatic system in Pantothenase kinase associated neurodegeneration (PKAN)

Parkinsonism & Related Disorders
To investigate if accumulation of iron in the globus pallidus as seen in patients suffering from Pantothenase Kinase Associated Neurodegeneration (PKAN), is related to damage of the cerebral glymphatic system.In a group of 24 patients and an age-matched control group, functionality of the glymphatic system was assessed by the index of Analysis aLong ...
Peter, Stoeter, Diones, Rivera, Pedro, Roa, Herwin, Speckter, Cesarina, Torres   +4 more
openaire   +2 more sources

Grey matter alterations in patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN)

Parkinsonism & Related Disorders, 2014
Pantothenate Kinase-Associated Neurodegeneration (PKAN) is a rare heritable disease marked by dystonia and loss of movement control. In contrast to the well-known "Eye-of-the-Tiger" sign affecting the globus pallidus, little is known about other deviations of brain morphology, especially about grey matter changes.We investigated 29 patients with PKAN ...
Rea Rodriguez-Raecke, Pedro Roa-Sanchez, Herwin Speckter, Rafael Fermin-Delgado, Eddy Perez-Then, Jairo Oviedo, Peter Stoeter   +6 more
openaire   +2 more sources

Subthalamic Nuclei Stimulation in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)

Neuromodulation: Technology at the Neural Interface, 2017
Pantothenate kinase-associated neurodegeneration (PKAN) is a rare autosomal recessive genetic disease that leads to extrapyramidal symptoms, such as dystonia, ataxia, dysarthria, and involuntary movements. Treatment of PKAN with deep brain stimulation (DBS) has been reported, but mainly focuses on targeting the globus pallidus internus (GPi ...
Ziyuan, Liu, Yang, Liu, Yingmai, Yang, Lin, Wang, Wanchen, Dou, Jinzhu, Guo, Yu, Wang, Yi, Guo, Xinhua, Wan, Wenbin, Ma, Renzhi, Wang   +10 more
openaire   +2 more sources

PKAN

2023
Kevin R. Moore, Anna Illner, Hans-Christian Bauknecht   +2 more
openaire   +1 more source

USEFULNESS OF BRAIN MRI IN DIAGNOSIS OF NBIA IN PKAN AND NON-PKAN PATIENTS

Neuropediatrics, 2006
T Kmiec, E Jurkiewicz, S Jozwiak, I Pakula-Kosciesza, M Ebhart, H Prokisch   +5 more
openaire   +1 more source

A Case of MPAN with “Eye of the Tiger Sign,” Mimicking PKAN

Movement Disorders Clinical Practice, 2022
Masoumeh, Dehghan Manshadi, Mohammd, Rohani, Ali, Rezaei, Omid, Aryani   +3 more
openaire   +2 more sources

Basal ganglia calcification in a case of PKAN

Parkinsonism & Related Disorders, 2017
Alfonso Fasano, Gholamali Shahidi, Anthony E. Lang, Mohammad Rohani   +3 more
openaire   +1 more source

Deep Brain Stimulation (DBS) with Subthalamic Nucleus (STN) as Target for Pediatric Patients with PKAN

World Neurosurgery, 2022
Dapeng Li, Wuyang Yang, Huifang Yan
exaly  

Modeling PKAN in Mice and Flies

2015
Ody Sibon, Susan Hayflick, Valeria Tiranti   +2 more
openaire   +1 more source